Breaking News
Subscribe Now 0
Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 place See list

Edison

  • Analysis & Opinion

Edison 's Opinion & Analysis
A complete archive of Edison 's articles, including current analysis & opinion - Page 10

Keywords Studios Plc (LON:KWS) saw strong revenue growth in H119 (17.5% like-for-like, l-f-l) and although investment and some one-off factors compressed margins, the company looks well placed to...
Having reported H119 financials, Asit C Mehta Financial Services Ltd (BO:ASIT) main focus remains on the results of the second Phase III study of gp-ASIT+ for the prevention of grass...
The past few months have been transformative for RhoVac ApS (TE:RHOVAC). The company completed a large rights issue, published final follow-up results from its Phase I/II trial with RV001 in...
In a pre-close statement ahead of Avon Rubber's (LON:AVON) FY19 year-end, management has indicated the strong momentum in Avon Protection continued through H219. Group performance was also...
Cohort (LON:CHRT) AGM statement indicates the current year has progressed well, with order cover of sales for the year rising to 76% following recent September orders compared to 60% at the same point...
Petro Matad Ltd (LON:MATD) announced yesterday that the Red Deer-1 well in Block XX in Mongolia did not encounter hydrocarbons. The well was the second in a three well exploration and appraisal...
Scherzer & Co AG (DE:PZSG) NAV closed H119 flat vs end FY18 and declined 3.5% to the end of August. H119 portfolio performance was dominated by weaker results from GK Software and pre-squeeze-out...
Heliad Equity Partners KGAA (DE:HPBGn) is repositioning its portfolio following the management changes earlier this year. This involves the gradual disposal of holdings in listed companies (with...
On 24 August 2019, Canacol Energy Ltd . (TSX:CNE) achieved a record production of 217mmscfd of natural gas. This is a significant milestone for the company in Colombia, as it has now surpassed...
Onxeo (CSE:ONXEO) is focused on the development of the next generation of DNA damage repair inhibitors from its novel oligonucleotide platON platform. The lead asset, AsiDNA, belongs to the same class...